The Ross operation in children–what is the long-term fate of the autograft?
Clicks: 2
ID: 319134
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #59 of 85 articles by views in Interdisciplinary CardioVascular and Thoracic Surgery
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Objectives The Ross operation achieves excellent outcomes in children and adolescents, but the influence of age at surgery and underlying pathology on long-term results remains uncertain. Evidence on autograft dilatation necessitating reintervention is also limited. This study aimed to identify patient groups best served from the Ross procedure and to evaluate long-term autograft performance. Methods All consecutive patients <18 years undergoing a Ross or Ross–Konno procedure between 1991–2024 at a single centre were analysed. Demographic, operative, and follow-up data were collected. Patients were stratified into age groups (neonate, infant, child, adolescent) and diagnostic groups (isolated aortic valve disease, aortic stenosis with subaortic stenosis, Shone’s complex, and complex congenital heart disease [CHD]). Outcomes included overall survival, freedom from autograft and right ventricle–pulmonary artery (RV-PA) conduit reintervention, and severe autograft dilatation (>50 mm or > 25 mm/m2). Results A total of 226 patients underwent surgery at a median age of 8.5 years; 67% were male. Median follow-up was 9.5 years(IQR 12.7). Operative mortality was 2% and overall mortality 5%. Survival exceeded 90% at 30 years in all groups except neonates (60% at 5 years). After adjustment for age, Shone’s complex and complex CHD were associated with an 11-fold and 8.8-fold increased hazard of death, respectively (p < 0.03). Freedom from autograft reintervention was 82% and from RV-PA conduit reintervention 66% at 25 years. Freedom from severe autograft dilatation was 71% at 20 years by absolute dimension and 54% when indexed to BSA. Greater than mild aortic regurgitation at discharge conferred a 17-fold risk of autograft intervention (p < 0.001). Conclusions The Ross procedure provides excellent long-term survival and valve durability in children and adolescents, particularly those with isolated aortic valve disease. Autograft dilatation and conduit reintervention remain important late risks, reinforcing the need for lifelong surveillance in specialized centres.
| Reference Key |
openalex_W7166564146
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Nabil Hussein, Tristan Ramcharan, Joseph George, Natasha Khan, Timothy J. Jones, Phil Botha |
| Journal | Interdisciplinary CardioVascular and Thoracic Surgery |
| Year | 2026 |
| DOI |
10.1093/icvts/ivag176
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.